Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderich E Schwarz

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
American Journal of Respiratory Cell and Molecular Biology|June 3, 2016
Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of PrematurityDaniel D Lee, Charitharth V Lal, Elizabeth A Persad, et al.
Cancer Biology & Therapy|December 9, 2021
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer modelsKate Crawford, Erin Bontrager, Margaret A Schwarz, et al.
Journal of the American College of Surgeons|November 1, 2005
Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sitesJoshua D I Ellenhorn, David D Smith, Roderich E Schwarz, et al.
Cancer Letters|February 3, 2015
CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancerZhe-Wei Wei, Guang-Kai Xia, Ying Wu, et al.
Radiation Oncology (London, England)|November 1, 2011
Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancerJohn H Heinzerling, Ross Bland, John C Mansour, et al.
Annals of Surgical Oncology|May 13, 2015
A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver MetastasesJeffrey J Meyer, Ryan D Foster, Naama Lev-Cohain, et al.
Nature Reviews. Clinical Oncology|May 25, 2011
The role of local therapy in the management of lung and liver oligometastasesSimon S Lo, Susan D Moffatt-Bruce, Laura A Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66Steven R Alberts, Mark S Roh, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
American Journal of Respiratory Cell and Molecular Biology|June 3, 2016
Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of PrematurityDaniel D Lee, Charitharth V Lal, Elizabeth A Persad, et al.
Cancer Biology & Therapy|December 9, 2021
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer modelsKate Crawford, Erin Bontrager, Margaret A Schwarz, et al.
Journal of the American College of Surgeons|November 1, 2005
Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sitesJoshua D I Ellenhorn, David D Smith, Roderich E Schwarz, et al.
Cancer Letters|February 3, 2015
CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancerZhe-Wei Wei, Guang-Kai Xia, Ying Wu, et al.
Radiation Oncology (London, England)|November 1, 2011
Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancerJohn H Heinzerling, Ross Bland, John C Mansour, et al.
Annals of Surgical Oncology|May 13, 2015
A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver MetastasesJeffrey J Meyer, Ryan D Foster, Naama Lev-Cohain, et al.
Nature Reviews. Clinical Oncology|May 25, 2011
The role of local therapy in the management of lung and liver oligometastasesSimon S Lo, Susan D Moffatt-Bruce, Laura A Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66Steven R Alberts, Mark S Roh, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Pageof 11